Medical Weight Loss in Salt Lake City, UT

Semaglutide (Ozempic) treatments are generally used to treat overweight or obese patients who have a BMI over 27 and have some of the following weight related issues including type 2 diabetes, hypertension, or high cholesterol. If you are simply someone who wants to lose weight, come in for a consultation and we can discuss your health history along with your weight and health goals.

You are not a good candidate for Ozempic weight loss injections if you have any of the following conditions: decreased kidney function, multiple endocrine neoplasia type 2, diabetic retinopathy, decreased kidney function, or medullary thyroid cancer (or family history of).

Medical weight loss treatments can have a profound impact on your body, extending beyond just reducing pounds on the scale. These interventions often target underlying physiological processes, such as regulating appetite, improving insulin sensitivity, and enhancing metabolism. By addressing these factors, medical weight loss can lead to more sustainable fat loss, reduced body fat percentage, and better overall metabolic health. Additionally, successful weight loss can alleviate strain on joints, improve cardiovascular health, and enhance energy levels. As a result, individuals often experience not only a healthier body composition but also a boost in overall well-being and quality of life.

Semaglutide is used primarily as an injectable medication for managing type 2 diabetes and aiding in weight loss. It is typically administered once a week via a subcutaneous injection, commonly in the abdomen, thigh, or upper arm. Proper storage of Semaglutide is crucial to maintain its effectiveness; it should be kept refrigerated at temperatures between 36°F and 46°F (2°C and 8°C) until use. Avoid freezing the medication, as it can reduce its efficacy. Your UFP provider will go over injecting and storage with you to ensure proper usage.

The worthiness of using these treatments for weight loss depends on individual circumstances, health goals, and discussions with one of our healthcare professionals. Semaglutide and Tirzapeptide have shown effectiveness in promoting weight loss, making it a valuable option for those struggling with obesity. However, like any medication, it comes with potential side effects and considerations.

If an individual has both type 2 diabetes and obesity, these treatments may offer a dual benefit by addressing both conditions. It's essential to consult with a healthcare provider to determine if Semaglutide or Tirzapeptide are suitable options based on the person's overall health, medical history, and specific weight loss goals.

It's important to note that lifestyle modifications, including diet and exercise, remain fundamental for sustainable weight management. Semaglutide and Tirzapeptide are typically prescribed in conjunction with a comprehensive weight loss plan. Therefore, the decision to use these treatments should be part of a broader strategy tailored to an individual's health needs and objectives.

Semaglutide, Tirzepatide, and Ozempic are all medications used to aid in weight loss and manage metabolic health, but they have distinct differences in their mechanisms and applications. Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and improve insulin sensitivity, leading to effective weight loss and better blood sugar control. Ozempic is actually a brand name for Semaglutide, specifically used for managing type 2 diabetes, though it also contributes to weight loss. Tirzepatide, on the other hand, is a newer medication that combines the effects of GLP-1 and GIP receptor agonists, targeting both appetite and glucose regulation for potentially enhanced results in weight loss and metabolic health. While all three can help with weight management, Tirzepatide’s dual action may offer additional benefits over Semaglutide alone.

Medical weight loss treatments like semaglutide and tirzepatide can be highly effective, but they also come with potential risks and side effects. Common issues include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which are particularly prevalent with GLP-1 receptor agonists. Other risks can include potential impacts on kidney function, increased heart rate, and, in rare cases, pancreatitis. Individuals with a history of certain health conditions, such as thyroid cancer or multiple endocrine neoplasia syndrome, may be advised against using these medications. It's crucial for patients to work closely with their healthcare providers to monitor their health and address any adverse effects promptly.

The amount of weight loss achieved with semaglutide can vary from person to person and is influenced by several factors, including individual characteristics, lifestyle, and adherence to the prescribed treatment plan. Clinical studies have demonstrated that these treatments can lead to significant weight loss in some individuals.

It's important to note that the effectiveness of Semaglutide and Tirzapeptide is typically observed when it is used as part of a comprehensive weight management program, including a reduced-calorie diet and increased physical activity.

Individual responses to Semaglutide and Tirzapeptide can differ, and not everyone may experience the same level of weight loss. Additionally, the use of these treatments should be supervised by a healthcare professional who can tailor the treatment plan to an individual's health needs and monitor for potential side effects. If considering Semaglutide or Tirzapeptide for weight loss, it's crucial to consult with a healthcare provider to determine its appropriateness and establish realistic expectations based on individual circumstances.

Many patients notice reduced appetite within the first few weeks. Weight loss typically becomes noticeable within the first 1–2 months, with continued progress over time.

Some patients experience mild nausea, constipation, or fatigue during dose adjustments. These effects are usually temporary and managed through gradual dosing and clinical guidance.

Semaglutide works best when combined with healthy eating and movement habits. Our team supports realistic, sustainable lifestyle changes—not extreme restriction.

Treatment length varies based on individual goals and response. Your provider will help determine the best long-term plan for success and maintenance.

Semaglutide is given as a subcutaneous injection, typically administered at home. Treatment begins with a low dose and is gradually increased over time to support comfort, tolerance, and effectiveness under medical supervision.

When consulting with our patients on surgical procedures, we often have patients who want to lose weight or wonder if they should lose weight before having a procedure. Weight loss can cause added volume loss and skin laxity, which are things that are being addressed particularly in many of our facial cosmetic procedures.

Our providers recommend that if you want to lose more than 20-30 pounds, that it is best to do so before having procedure such as facelift or fat grafting. Semaglutide or Tirzapeptide weight loss treatments may be an added option for you so that you can kick start your weight loss goals and also achieve the best outcome with your procedure.

Anytime you embark on a weight loss journey, it is important to incorporate a healthy diet along with exercise to achieve the best results and develop positive life long habits. UFP has partnered with Total Health and Fitness in Draper, Utah (near Salt Lake City) to assist our patients with their overall health goals.